Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Factor VIII Deficiency”

265 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 265 results

Early research (Phase 1)Study completedNCT01561924
What this trial is testing

Prediction of the Efficacy of Activated Recombinant Human Factor VII in Adult Congenital Haemophilia A or B Patients With Inhibitors by Use of Thromboelastography

Who this might be right for
Congenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With Inhibitors
Novo Nordisk A/S 17
Post-approval studies (Phase 4)Study completedNCT03103542
What this trial is testing

Study of rFVIIIFc for Immune Tolerance Induction (ITI) in Haemophilia A Patients With Inhibitors Who Have Failed Previous ITI Therapies

Who this might be right for
Hemophilia A
Swedish Orphan Biovitrum 16
Not applicableStudy completedNCT04334057
What this trial is testing

Post-Marketing Surveillance (Use-results Surveillance) With Esperoct®

Who this might be right for
Haemophilia A
Novo Nordisk A/S 23
Not applicableStudy completedNCT00703911
What this trial is testing

Observational Registry of NovoSeven® Used as On-demand Treatment of Bleeds in Patients With Haemophilia A and B With Inhibitors

Who this might be right for
Congenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With Inhibitors
Novo Nordisk A/S 102
Testing effectiveness (Phase 2)Study completedNCT04073498
What this trial is testing

The Safety and Tolerability of SerpinPC in Healthy Men and in Men with Severe Blood Disorders (haemophilia a and B)

Who this might be right for
Hemophilia aHemophilia B
ApcinteX Ltd 39
Large-scale testing (Phase 3)Ended earlyNCT01434511
What this trial is testing

Study of Modified Recombinant Factor VIII (OBI-1) in Subjects With Congenital Hemophilia A

Who this might be right for
Hemophilia A
Baxalta now part of Shire 1
Large-scale testing (Phase 3)Study completedNCT00157053
What this trial is testing

Study of Pharmacokinetics, Efficacy and Safety of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients - A Continuation of Clinical Study 069901

Who this might be right for
Hemophilia A
Baxalta now part of Shire 82
Early research (Phase 1)Study completedNCT00837356
What this trial is testing

Comparison of the Action of Drugs in the Body and Safety of N8 and Advate® in Haemophilia A Subjects

Who this might be right for
Congenital Bleeding DisorderHaemophilia A
Novo Nordisk A/S 23
Not applicableUnknownNCT01856751
What this trial is testing

Use of a TGA and TEM in the Assessment of the Efficacy of Treatment With APCC or rFVIIa

Who this might be right for
Haemophilia
Stowarzyszenie Pomocy Chorym na Zakrzepicę i Skazy Krwotoczne Thrombus 80
Not applicableStudy completedNCT00882778
What this trial is testing

PROPACT: Retrospective Prophylaxis Patient Case Collection

Who this might be right for
Congenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With Inhibitors
Novo Nordisk A/S 86
Post-approval studies (Phase 4)WithdrawnNCT00151385
What this trial is testing

Study Evaluating Inhibitor Specificity in Hemophilia A

Who this might be right for
Hemophilia A
Wyeth is now a wholly owned subsidiary of Pfizer
Not applicableStudy completedNCT02190149
What this trial is testing

Study of Prophylaxis, ACtivity and Effectiveness (SPACE) in Hemophilia Patients Currently Treated With ADVATE or RIXUBIS

Who this might be right for
Hemophilia AHemophilia B
Baxalta now part of Shire 64
Not applicableEnded earlyNCT02402829
What this trial is testing

A Study Comparing Factor Level and Inhibitor Titer Testing Results Drawn From Central Venous Lines and Venipuncture

Who this might be right for
Hemophilia AFactor VIII DeficiencyHemophilia+2 more
Children's Mercy Hospital Kansas City 3
Not applicableEnrolling By InvitationNCT04682145
What this trial is testing

Adverse Event Data Collection From the EUHASS Registry on Turoctocog Alfa Pegol

Who this might be right for
Haemophilia A
Novo Nordisk A/S 50
Not applicableStudy completedNCT01436825
What this trial is testing

Validation Study of a cOmputer Pharmacokinetic Tool to assIst in the Follow up Care of haeMophilia A Patients

Who this might be right for
Haemophilia A
Bayer 69
Not applicableWithdrawnNCT01541527
What this trial is testing

Non Neutralizing Antibodies: Prevalence and Characterization

Who this might be right for
Hemophilia A
University Hospital, Montpellier
Early research (Phase 1)Study completedNCT00000705
What this trial is testing

Safety and Effectiveness of Azidothymidine (AZT) in HIV-Positive Patients With Hemophilia

Who this might be right for
HIV InfectionsHemophilia A
National Institute of Allergy and Infectious Diseases (NIAID) 24
Early research (Phase 1)Looking for participantsNCT06349473
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)

Who this might be right for
Healthy ParticipantsHemophilia AHemophilia B+1 more
Equilibra Bioscience LLC 36
Post-approval studies (Phase 4)Study completedNCT02697370
What this trial is testing

Efficacy and Cost Effectiveness of Pharmacokinetic Dosing in Haemophilia A

Who this might be right for
Severe Haemophilia A
Hampshire Hospitals NHS Foundation Trust 20
Early research (Phase 1)Study completedNCT01692925
What this trial is testing

Investigation of the Pharmacokinetics of Turoctocog Alfa in Subjects With Haemophilia A

Who this might be right for
Congenital Bleeding DisorderHaemophilia A
Novo Nordisk A/S 15
Load More Results